Breaking News

MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. – MYL

Kahn Swick & Foti, LLC via Globe Newswire 03:07 GMT Saturday 3rd December 2016

NEW ORLEANS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until to file lead plaintiff applications in a securities class action lawsuit against Mylan N.V. (Nasdaq:MYL), if they purchased the Company’s securities between February 21, 2012 and October 7, 2016, inclusive (the “Class Period”).  This action is pending in the United States District Court for the Southern District of New York.What You May DoIf you purchased securities of Mylan and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by .About the LawsuitMylan and certain of its executives are charged with ...

Read the whole story...

STONEMOR SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against StoneMor Partners L.P. – STON

NEW ORLEANS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until to file lead plaintiff applications in a securities...[Published 03-12-2016 03:07:00 GMT]

GOPRO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against GoPro, Inc. - GPRO

NEW ORLEANS, LA--(Marketwired - December 02, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 17, 2017 to file lead plaintiff ap...[Published 03-12-2016 03:07:00 GMT]

TREEHOUSE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Treehouse Foods, Inc. - THS

NEW ORLEANS, LA--(Marketwired - December 02, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 17, 2017 to file lead plaintiff app...[Published 03-12-2016 03:07:00 GMT]

COGNIZANT 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Cognizant Technology Solutions Corporation - CTSH

NEW ORLEANS, LA--(Marketwired - December 02, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until Decemb...[Published 03-12-2016 03:07:00 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

NEW YORK, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Stull, Stull & Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and CFO Kenneth...[Published 03-12-2016 01:52:27 GMT]

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2016. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers